#BioTech

Biotech firms are gaining major traction in 2026 due to the global pandemic. Take a look at some of the key features of biotech stocks before investing.

Your Pipeline Is 26.0h Behind: Catching Biotech Sentiment Leads with Pulsebit We recently...

Krystal Biotech, Inc. (KRYS) Bank of America Global Healthcare Conference 2026 May 13, 2026 2:20 PM EDTCompany ParticipantsKrish Krishnan - Founder,...

From Dev.to - nlp: Your Pipeline Is 26.6h Behind: Catching Biotech Sentiment Leads with Pulsebit

Healthcare intelligence platforms are evolving beyond static reporting. SPER’s CAR-T Navigator...

FDA drug approvals are reshaping biotech stocks—track key decisions, FDA leadership turmoil, and volatility. Click for a look at the issues surrounding the FDA.

Biotech penny stocks offer a huge investment opportunity. Check out Benzinga's list of great biotech stocks above.

From Dev RSS Feed: Can You Steer It? Introducing SEWO — A Steerable Medicine World Model Framework

China has been closing the gap with the US in biotech and pharmaceutical research, with the proportion of studies being conducted by Chinese scientists increasing.…

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.”

Bootstrap Bio and Manhattan Genomics, which were pursuing human embryo editing to prevent serious disease, have shut down.

Paterna Biosciences says it has determined the set of instructions needed to turn sperm-making stem cells into "normal, mature" sperm.

New strategies will be necessary for biotechnology companies to thrive in the new era of personalized medicine, but the healthcare system itself will also have to change, according to a panel of biotechnology company representatives at the 2008 Wharton…

When Grammy-nominated singer-songwriter Aloe Blacc got COVID despite being vaccinated and boosted, he tried to fund research for a better solution. What he quickly found out? You can’t just write a check in biotech.…

Laigo Bio has closed a €17M seed round to advance its SureTACs platform, which degrades cancer-driving membrane proteins rather than blocking them.

Researchers use directed evolution to create magneto-sensitive fluorescent proteins that can interact with magnetic fields and radio waves